학술논문
Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study
Document Type
Article
Author
Source
In Clinical Lung Cancer May 2023 24(3):218-227
Subject
Language
ISSN
1525-7304